AI-guided solutions to
improve health outcomes for
mothers and their babies
Oli: Working to address unmet needs in women’s health
Oli has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).
Oli PPH is aiming to save lives and reduce the occurrence of irreversibly debilitating outcomes such as emergency hysterectomy, associated with the leading cause of preventable maternal death.
birth experience.
Determined to prove to the world
we can do better.
Latest News
Baymatob Appoints Two New Directors to the Board
Baymatob is very happy to share that Lisa McIntyre and Tamara Mills have been appointed as non-executive directors of the company in March 2024. “ We are fortunate to have been able to attract two...
Oli Selected as a Finalist in 2023 InnovationAus Awards for Excellence
We are excited to have been announced as a finalist in the 2023 InnovationAus A wards for Excellence in the Health Tech category . These awards showcase the innovation-led approach we are taking to...
Video: Channel 9 News Features Completion of Baymatob Pilot Study
In our completed 500-patient Pilot study, Oli has shown significant promise in being able to provide early-warning for post-partum hemorrhage - the leading cause of preventable maternal death,...